Volume 21, Number 3—March 2015
Dispatch
Increased Risk for Multidrug-Resistant Tuberculosis in Migratory Workers, Armenia
Nune Truzyan
, Byron Crape, Ruzanna Grigoryan, Hripsime Martirosyan, and Varduhi Petrosyan
, Byron Crape, Ruzanna Grigoryan, Hripsime Martirosyan, and Varduhi Petrosyan
Table 3
Associations between outcome variable of having 1 treatment versus multiple treatments for tuberculosis and potential risk factors for multiple treatments by bivariate and multivariate logistic regressions, for migrant workers, Armenia, 2008–2011*
| Variable | Bivariate analysis |
Multivariate analysis |
||
|---|---|---|---|---|
| Crude odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | |
| DOT during ambulatory phase of first treatment | ||||
| Always or often | 1.00 | NA | 1.00 | NA |
| Sometimes or never | 3.97 (1.2–13.3) | 0.03† | 4.36 (1.3–14.9) | 0.02† |
| Having MDR TB | ||||
| No | 1.00 | NA | 1.00 | NA |
| Yes | 2.11 (0.9–4.4) | 0.05† | 2.30 (1.1–5.0) | 0.04† |
| Density of persons working in the same enclosed area in host country | NI | NI | ||
| 1–5 | 1.00 | NA | ||
| ≥6 | 0.15 (0.02–1.3) | 0.08 | ||
| Crowding index for residence in host country | NI | NI | ||
| <2.0 | 1.00 | NA | ||
| ≥2.0 | 1.68 (0.5–5.6) | 0.39 | ||
| Crowding index for residence in Armenia | NI | NI | ||
| <2.0 | 1.00 | NA | ||
| ≥2.0 | 1.28 (0.3–6.6) | 0.77 | ||
| No. visits to the host country of work | NI | NI | ||
| 1 | 1.00 | NA | ||
| >1 | 1.04 (0.4–2.6) | 0.94 | ||
| Type of work performed in host country | NI | NI | ||
| Other | 1.00 | NA | ||
| Construction | 1.82 (0.7–4.9) | 0.24 | ||
| Family member/relatives/friends having TB | NI | NI | ||
| No | 1.00 | NA | ||
| Yes | 0.84 (0.2–2.8) | 0.77 | ||
| TB knowledge score | NI | NI | ||
| High (13–20) | 1.00 | NA | ||
| Low (2–12) | 1.30 (0.5–3.3) | 0.58 | ||
| Education, y | NI | NI | ||
| >12 | 1.00 | NA | ||
| ≤12 | 1.31 (0.5–3.4) | 0.58 | ||
| Marital status | NI | NI | ||
| Married | 1.00 | NA | ||
| Single/divorced/separated | 0.99 (0.3–2.6) | 0.84 | ||
| Wealth status | NI | NI | ||
| Not poor | 1.00 | NA | ||
| Poor | 2.38 (0.5–11.5) | 0.28 | ||
*DOT, directly observed therapy; NA, not applicable; MDR TB, multidrug-resistant tuberculosis; NI, not included.
†Significant association (p≤0.05).
Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.